Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
71.00    2.00 (2.90%)
Bid:
70.00
Ask:
72.00
Spread: 2.00 (2.857%)
Market Cap: £55.96m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Placing of Shares

26 May 2006 07:01

Hardide PLC26 May 2006 Press Release 26 May 2006 Hardide Plc ("Hardide" or "the Company") Placing of Shares Hardide Plc (AIM:HDD), the provider of unique surface engineering technologyannounces that it has conditionally raised £1.55 million (before expenses) forthe Company via a placing for cash of 12,386,832 Ordinary Shares of 1 pence each("Ordinary Shares") at 12.5 pence per share ("the Placing"). In addition,601,650 Ordinary Shares held by Dr Yuri Zhuk, Technical Director of Hardide, and8,598,350 Ordinary Shares held by Flintstone Management Services Limited ("FMS"), a subsidiary of Proventec PLC, have also been placed at the placingprice with institutional and other investors. The net receivable proceeds of the Placing will be used to fund the Company'scontinuing expansion. Mr David Chestnutt, non-executive Chairman of Hardide, is also a director ofFMS. FMS has undertaken not to dispose of any further Ordinary Shares withoutthe permission of the Company's broker, Daniel Stewart & Co plc, before 30November 2006. Application has been made for the admission of the 12,386,832 Ordinary Sharessubject to the Placing to be admitted to trading on AIM ("Admission"). It isexpected that Admission will take place on 1 June 2006. At Admission, theCompany will have 146,742,236 Ordinary Shares in issue. Jim Murray-Smith, Chief Executive of the Company, has subscribed for 200,000Ordinary Shares in the Placing. Following Admission, Mr Murray-Smith will havean interest in 428,000 Ordinary Shares, representing 0.27% of the issued sharecapital. Following Admission, Dr Zhuk will have a residual interest in 4,364,465 OrdinaryShares, representing 2.97% of the issued share capital. Following Admission, FMS will have a residual interest in 31,499,725 OrdinaryShares, representing 21.47% of the issued share capital. Commenting on the Placing, Jim Murray-Smith, Chief Executive of Hardide Plc,said: "The proceeds from the Placing will enable the Company to strengthen thesenior management team, underpin and accelerate expansion in the US. Initialindications from the US oil, gas and pump markets continue to suggest extremelyhigh demand for Hardide's unique products. The opening of our new manufacturingfacility in Houston is still on schedule for October 2006. We have been particularly encouraged by the strong demand from both existing andnew institutional investors and look forward to sharing Hardide's future successwith them. The Board remains confident of meeting market expectations for thefull year." For further information: Hardide plc Jim Murray Smith, Chief Executive Tel: +44 (0) 1869 353 830 jmurray-smith@hardide.com www.hardide.com Daniel Stewart & Company plc Paul Shackleton, Corporate Finance Tel: +44 (0) 20 7776 6550 www.danielstewart.co.uk Media enquiries: Abchurch Chris Lane / Katherine Murphy Tel: +44 (0) 20 7398 7700 chris.lane@abchurch-group.com www.abchurch-group.com Notes to editors Hardide provides and applies tungsten carbide coatings to a wide range ofengineering components. The Company's patented technology is unique in that itcombines both abrasion and corrosion resistant properties in one coating. Whenapplied to components, the technology is proven to offer dramatic cost savingsthrough reduced downtime and extended component life. Customers include leadingcompanies operating in oil and gas exploration and production, valve and pumpsmanufacturing and general engineering. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Oct 20077:01 amRNSGas Supply Agreement
5th Oct 20079:01 amRNSDebt Fundraising Complete
20th Sep 20077:01 amRNSFDA approval
3rd Sep 20077:01 amRNSRe: Orders
30th Aug 20077:01 amRNSChange of registered address
21st Aug 20077:00 amRNSAerospace - development plans
3rd Aug 20077:00 amRNSAIM rule 26 compliance
26th Jun 20077:01 amRNSDirectorate Appointment
14th May 20077:01 amRNSInterim Results
23rd Apr 20077:00 amRNSNotice of Results
2nd Apr 20079:17 amRNSChange of Adviser
22nd Mar 200711:40 amRNSHolding(s) in Company
13th Mar 20074:47 pmRNSHolding(s) in Company
13th Mar 20074:46 pmRNSHolding(s) in Company
19th Feb 20077:01 amRNSUS Order
13th Feb 20076:02 pmRNSHolding(s) in Company
12th Feb 20077:01 amRNSSale of holding in Hardide
12th Feb 20077:01 amRNSDirectorate Change
29th Jan 20075:07 pmRNSResult of AGM
21st Dec 20065:27 pmRNSTotal Voting Rights
8th Dec 20063:35 pmRNSHolding(s) in Company
7th Dec 20067:01 amRNSDirector/PDMR Shareholding
6th Dec 20067:01 amRNSDirector/PDMR Shareholding
4th Dec 20067:01 amRNSFinal Results
27th Nov 20067:00 amRNSNotice of Results
14th Nov 20061:39 pmRNSBlock Listing Return
4th Oct 20064:25 pmRNSHolding(s) in Company
19th Sep 200610:19 amRNSHolding(s) in Company
19th Sep 200610:13 amRNSHolding(s) in Company
7th Sep 20067:02 amRNSPatent Announcement
1st Aug 20067:02 amRNSDirector/PDMR Shareholding
31st Jul 200610:48 amRNSTrading Statement
29th Jun 200612:00 pmRNSHolding(s) in Company
30th May 20062:50 pmRNSHolding(s) in Company
26th May 20067:02 amRNSReduced holding in Hardide
26th May 20067:01 amRNSPlacing of Shares
16th May 200612:35 pmRNSHolding(s) in Company
15th May 20067:02 amRNSBlock Admission Application
8th May 20069:10 amRNSInterim Results - Amendment
8th May 20067:01 amRNSInterim Results
2nd May 20067:01 amRNSUpdate on US facility
28th Apr 20067:01 amRNSChange of Adviser
28th Apr 20067:01 amRNSNotice of Results
21st Mar 20067:00 amRNSDirectorate Change
13th Mar 20067:00 amRNSTrading Update
28th Feb 20064:55 pmRNSAdditional Listing
21st Dec 200511:00 amRNSIssue of Equity
13th Dec 20057:00 amRNSFinal Results
9th Nov 20057:00 amRNSNotice of Results
28th Jun 20051:26 pmRNSInterim Results - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.